The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a

Biomaterials

Volumn 34, Issue 1, 2013, Pages 92-99

  Lee, Se Yeon ^a   Ham, Onju ^a   Cha, Min Ji ^a   Song, Byeong Wook ^a   Choi, Eunmi ^b   Kim, Il Kwon ^c   Chang, Woochul ^d   Lim, Soyeon ^e   Lee, Chang Youn ^a   Park, Jun Hee ^a   Lee, Jiyun ^a   Bae, Yoonjin ^a   Seo, Hyang Hee ^a   Choi, Eunhyun ^e   Jang, Yangsoo ^a   Hwang, Ki Chul ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d The Catholic University of Korea   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Cardiogenic differentiation; Compound 56; EGFR; Mesenchymal stem cells; MicroRNA 133a

Indexed keywords

CARDIOMYOCYTES; CELL THERAPY; COMPOUND 56; EGFR; EPIDERMAL GROWTH FACTOR RECEPTORS; HEART DISEASE; HEART FUNCTION; HUMAN BONES; LUCIFERASE ACTIVITIES; MESENCHYMAL STEM CELL; MICRORNA-133A;

CELL CULTURE; STEM CELLS;

RNA;

4 [(3 BROMOPHENYL)AMINO] 6,7 DIETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; LUCIFERASE; MICRORNA; MICRORNA 133A; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; GENETIC TRANSFECTION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN TARGETING; STEM CELL TRANSPLANTATION;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CHO CELLS; CRICETINAE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICRORNAS; MOLECULAR SEQUENCE DATA; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; STEM CELL TRANSPLANTATION;

EID: 84868131987     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.069     Document Type: Article

References (34)

1. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005, 102:11474-11479.
2. Lim S.Y., Kim Y.S., Ahn Y., Jeong M.H., Hong M.H., Joo S.Y., et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 2006, 70:530-542.
3. Wisel S., Khan M., Kuppusamy M.L., Mohan I.K., Chacko S.M., Rivera B.K., et al. Pharmacological Preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazin) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Ther 2009, 329:543-550.
4. Zhao L., Hantash B.M. TGF-β1 regulates differentiation of bone marrow mesenchymal stem cells. Vitam Horm 2011, 87:127-141.
5. Xing Y., Lv A., Wang L., Yan X. The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem 2012, 360:279-287.
6. Schugar R.C., Robbins P.D., Deasy B.M. Small molecules in stem cell self-renewal and differentiation. Gene Ther 2008, 15:126-135.
7. Feng B., Ng J.H., Heng J.C., Ng H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009, 4:301-312.
8. Li W., Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci 2010, 31:36-45.
9. Barbaric I., Gokhale P.J., Jones M., Glen A., Baker D., Andrews P.W. Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies. Stem Cell Res 2010, 5:104-119.
10. Song H., Hwang H.J., Chang W., Song B.W., Cha M.J., Kim I.K., et al. Cardiomyocytes from phorbol myristate acetate-activated mesenchymal stem cells restore electromechanical function in infarcted rat hearts. Proc Natl Acad Sci USA 2011, 108:296-301.
11. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
12. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233.
13. Li Q., Lin X., Yang X., Chang J. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am J Physiol Heart Circ Physiol 2010, 298:H1340-H1347.
14. Horie T., Ono K., Nishi H., Iwanaga Y., Nagao K., Kinoshita M., et al. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochem Biophys Res Commun 2009, 389:315-320.
15. Myers T.J., Granero-Molto F., Longobardi L., Li T., Yan Y., Spagnoli A. Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther 2010, 10:1663-1679.
16. Chang W., Song B.W., Lim S., Song H., Shim C.Y., Cha M.J., et al. Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells 2009, 27:2283-2292.
17. Gnecchi M., He H., Noiseux N., Liang O.D., Zhang L., Morello F., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cellmediated cardiac protection and functional improvement. FASEB J 2006, 20:661-669.
18. Hahn J.Y., Cho H.J., Kang H.J., Kim T.S., Kim M.H., Chung J.H., et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 2008, 51:933-943.
19. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201.
20. Song H., Cha M.J., Song B.W., Kim I.K., Chang W., Lim S., et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 2010, 28:555-563.
21. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
22. Mohanty S., Bose S., Jain K.G., Bhargava B., Airan B. TGFβ1 contributes to cardiomyogenic-like differentiation of human bone marrow mesenchymal stem cells. Int J Cardiol 2011.
23. Qian Q., Qian H., Zhang X., Zhu W., Yan Y., Ye S., et al. 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev 2012, 21:67-75.
24. Chang M.G., Tung L., Sekar R.B., Chang C.Y., Cysyk J., Dong P., et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 2006, 113:1832-1841.
25. Wang T., Wang Y., Yamashita H. Evodiamine inhibits adipogenesis via the EGFR-PKCα-ERK signaling pathway. FEBS Lett 2009, 583:3655-3659.
26. Zhu J., Shimizu E., Zhang X., Partridge N.C., Qin L. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem 2011, 112:1749-1760.
27. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12:735-739.
28. Takaya T., Ono K., Kawamura T., Takanabe R., Kaichi S., Morimoto T., et al. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 2009, 73:1492-1497.
29. Huang S., Wang S., Bian C., Yang Z., Zhou H., Zeng Y., et al. Up-regulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 Protein Expression. Stem Cells Dev 2012, 21:2531-2540.
30. Kane N.M., Howard L., Descamps B., Meloni M., McClure J., Lu R., et al. Role for microRNAs 99b, 181a and 181b in the differentiation to vascular endothelial cells from human embryonic stem cells. Stem Cells 2012, 30:643-654.
31. Ham O., Song B.W., Lee S.Y., Choi E., Cha M.J., Lee C.Y., et al. The role of microRNA-23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling. Biomaterials 2012, 33:4500-4507.
32. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006, 103:18255-18260.
33. Hakuno D., Fukuda K., Makino S., Konishi F., Tomita Y., Manabe T., et al. Bone marrow-derived regenerated cardiomyocytes (CMGCells) express functional adrenergic and muscarinic receptors. Circulation 2002, 105:380-386.
34. Tao J., Wu D., Xu B., Qian W., Li P., Lu Q., et al. microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. Oncol Rep 2012, 27:1967-1975.